Fundz

British BioTech startup Houdini Bio has raised €1.7 million in pre-Seed funding led by SCVC to enhance DNA silencing in gene therapies.

PRIVATEJun 19, 2026

Amount Raised

€1.7 Million

Round Type

Pre-Seed

BiotechnologyHealth Care

Investors

Deep Science VenturesUniversity Of CambridgeScvc

Description

Houdini Bio has exited stealth with approximately €1.7 million in pre-Seed funding to validate its DNA sequence design infrastructure platform. The round was led by SCVC, with participation from Deep Science Ventures and the University of Cambridge. This funding will help Houdini Bio achieve technical milestones more rapidly. The company aims to provide effective solutions for genetic medicines by overcoming biological barriers.

Quick answer

Houdini Bio raised €1.7 Million in a Pre-Seed round, dated June 19, 2026. Investors: Deep Science Ventures, University Of Cambridge and Scvc.

How much did Houdini Bio raise?
Houdini Bio raised €1.7 Million in a Pre-Seed round on June 19, 2026.
Who invested in Houdini Bio?
Deep Science Ventures, University Of Cambridge and Scvc are named as investors in this round.
What does Houdini Bio do?
Houdini Bio is a DeepTech BioTech company that provides critical enabling infrastructure for next-generation genetic medicines.
Where is Houdini Bio based and how big is it?
Fundz records about 3 employees.
Who are the decision-makers at Houdini Bio?
Fundz holds 1 contact at Houdini Bio, including the Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Houdini Bio that raised within 45 days of this round, from Fundz verified event records.

  • Carebot raised $1.7M (Seed) on August 3, 2026.
  • Mediqstar raised an undisclosed amount (Series B) on August 3, 2026.
  • UN:BLOC raised an undisclosed amount (Seed) on August 3, 2026.
  • Inocras & Summit Pharmaceuticals International Corporation raised $31M (Series B) on August 3, 2026.
  • Obsidian Therapeutics raised $350M (Post-IPO Equity) on August 3, 2026.
  • GentiBio raised $1.2M (Grant) on August 2, 2026.

Who to call at Houdini Bio, and when

A new round usually means Houdini Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Houdini Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Houdini Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Houdini Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Houdini Bio

About

Houdini Bio is a DeepTech BioTech company that provides critical enabling infrastructure for next-generation genetic medicines. Founded in 2025, it combines machine learning with a mechanistic understanding of cellular silencing pathways to create a DNA rewiring toolkit. This toolkit aims to maximize transgene expression, durability, and scalability, transforming outcomes for patients suffering from various diseases. The company's platform addresses the biological barriers limiting the effectiveness of gene therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Houdini Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsLee, Co-FounderSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Houdini Bio's next move

See what Strategic adds

Houdini Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.